TY - JOUR
T1 - Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2
T2 - an electronic health record-based cohort study from the RECOVER Initiative
AU - RECOVER EHR and
AU - RECOVER Pediatric Cohorts
AU - Rao, Suchitra
AU - Azuero-Dajud, Rodrigo
AU - Lorman, Vitaly
AU - Landeo-Gutierrez, Jeremy
AU - Rhee, Kyung E.
AU - Ryu, Julie
AU - Kim, C.
AU - Carmilani, Megan
AU - Gross, Rachel S.
AU - Mohandas, Sindhu
AU - Suresh, Srinivasan
AU - Bailey, L. Charles
AU - Castro, Victor
AU - Senathirajah, Yalini
AU - Esquenazi-Karonika, Shari
AU - Murphy, Shawn
AU - Caddle, Steve
AU - Kleinman, Lawrence C.
AU - Castro-Baucom, Leah
AU - Oliveira, Carlos R.
AU - Klein, Jonathan D.
AU - Chung, Alicia
AU - Cowell, Lindsay G.
AU - Madlock-Brown, Charisse
AU - Geary, Carol Reynolds
AU - Sills, Marion R.
AU - Thorpe, Lorna E.
AU - Szmuszkovicz, Jacqueline
AU - Tantisira, Kelan G.
AU - Snowden, Jessica
AU - Irby, Katherine
AU - Darden, Paul
AU - Dixon, Lexie
AU - Evans, Danielle
AU - Garbe, Connor
AU - Hobart-Porter, Laura
AU - Howard, Lee
AU - Hummel, Kathy
AU - Krehbiel, Hannah
AU - Spradlin, Haley
AU - Yount, Phaedra
AU - Elliott, Amy
AU - Adam, Grace
AU - Angal, Jyoti
AU - Barber, Maria
AU - Clark, Katelynne
AU - Dos Reis, Clayton
AU - Freesemann, Mandy
AU - Aschner, Judy
AU - Clouser, Katharine
N1 - Publisher Copyright: © 2024
PY - 2025/2
Y1 - 2025/2
N2 - Background: Children from racial and ethnic minority groups are at greater risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but it is unclear whether they have increased risk for post-acute sequelae of SARS-CoV-2 (PASC). Our objectives were to assess whether the risk of respiratory and neurologic PASC differs by race/ethnicity and social drivers of health. Methods: We conducted a retrospective cohort study of individuals <21 years seeking care at 24 health systems across the U.S, using electronic health record (EHR) data. Our cohort included those with a positive SARS-CoV-2 molecular, serology or antigen test, or with a COVID-19, multisystem inflammatory disease in children, or PASC diagnosis from February 29, 2020 to August 1, 2022. We identified children/youth with at least 2 codes associated with respiratory and neurologic PASC. We measured associations between sociodemographic and clinical characteristics and respiratory and neurologic PASC using odds ratios and 95% confidence intervals estimated from multivariable logistic regression models adjusted for other sociodemographic characteristics, social vulnerability index or area deprivation index, time period of cohort entry, presence and complexity of chronic respiratory (respectively, neurologic) condition and healthcare utilization. Findings: Among 771,725 children in the cohort, 203,365 (26.3%) had SARS-CoV-2 infection. Among children with documented infection, 3217 children had respiratory PASC and 2009 children/youth had neurologic PASC. In logistic regression models, children <5 years (Odds Ratio [OR] 1.78, 95% CI 1.62–1.97), and of Hispanic White descent (OR 1.19, 95% CI 1.05–1.35) had higher odds of having respiratory PASC. Children/youth living in regions with higher area deprivation indices (OR 1.25, 95% CI 1.10–1.420 for 60–79th percentile) and with chronic complex respiratory conditions (OR 3.28, 95% CI 2.91–3.70) also had higher odds of respiratory PASC. In contrast, older (OR 1.57, 95% CI 1.40–1.77 for those aged 12–17 years), non-Hispanic White individuals and those with chronic pre-existing neurologic conditions (OR 2.04, 95% CI 1.78–2.35) were more likely to have a neurologic PASC diagnosis. Interpretation: Racial and ethnic differences in healthcare utilization for neurologic and respiratory PASC may reflect social drivers of health and inequities in access to care. Funding: National Institutes of Health.
AB - Background: Children from racial and ethnic minority groups are at greater risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but it is unclear whether they have increased risk for post-acute sequelae of SARS-CoV-2 (PASC). Our objectives were to assess whether the risk of respiratory and neurologic PASC differs by race/ethnicity and social drivers of health. Methods: We conducted a retrospective cohort study of individuals <21 years seeking care at 24 health systems across the U.S, using electronic health record (EHR) data. Our cohort included those with a positive SARS-CoV-2 molecular, serology or antigen test, or with a COVID-19, multisystem inflammatory disease in children, or PASC diagnosis from February 29, 2020 to August 1, 2022. We identified children/youth with at least 2 codes associated with respiratory and neurologic PASC. We measured associations between sociodemographic and clinical characteristics and respiratory and neurologic PASC using odds ratios and 95% confidence intervals estimated from multivariable logistic regression models adjusted for other sociodemographic characteristics, social vulnerability index or area deprivation index, time period of cohort entry, presence and complexity of chronic respiratory (respectively, neurologic) condition and healthcare utilization. Findings: Among 771,725 children in the cohort, 203,365 (26.3%) had SARS-CoV-2 infection. Among children with documented infection, 3217 children had respiratory PASC and 2009 children/youth had neurologic PASC. In logistic regression models, children <5 years (Odds Ratio [OR] 1.78, 95% CI 1.62–1.97), and of Hispanic White descent (OR 1.19, 95% CI 1.05–1.35) had higher odds of having respiratory PASC. Children/youth living in regions with higher area deprivation indices (OR 1.25, 95% CI 1.10–1.420 for 60–79th percentile) and with chronic complex respiratory conditions (OR 3.28, 95% CI 2.91–3.70) also had higher odds of respiratory PASC. In contrast, older (OR 1.57, 95% CI 1.40–1.77 for those aged 12–17 years), non-Hispanic White individuals and those with chronic pre-existing neurologic conditions (OR 2.04, 95% CI 1.78–2.35) were more likely to have a neurologic PASC diagnosis. Interpretation: Racial and ethnic differences in healthcare utilization for neurologic and respiratory PASC may reflect social drivers of health and inequities in access to care. Funding: National Institutes of Health.
KW - Chronic COVID-19 syndrome
KW - Ethnicity
KW - Late sequelae of COVID-19
KW - Long COVID
KW - Long-haul COVID
KW - Long-term COVID-19
KW - PCORnet
KW - PEDSnet
KW - Post-COVID condition
KW - Post-COVID syndrome
KW - Post-acute COVID-19
KW - Post-acute sequelae of SARS-CoV-2 infection
KW - Race
KW - Social determinants of health
UR - http://www.scopus.com/inward/record.url?scp=85214267549&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2024.103042
DO - 10.1016/j.eclinm.2024.103042
M3 - Article
SN - 2589-5370
VL - 80
JO - EClinicalMedicine
JF - EClinicalMedicine
M1 - 103042
ER -